Post Covid-Sequela: Novel-Inception of DM: A Review

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 16 | Issue : 02 | Page :
    By

    Michael Sanjeev Kumar,

  • Viji Michael Sanjeev Kumar,

  1. Associate Professor, Department of [Department Name], Bharathiar University, Coimbatore, Tamil Nadu, India
  2. Assistant Professor, Department of Applied Medical Sciences, University of Bisha, Al Namas, Saudi Arabia

Abstract

As patients recovers from COVID 19 pandemic, a subset of the covid patients experienced a post covid condition with long term symptoms, few weeks after their discharge or recovery from the (SARS-CoV-2) infection. Hence, we tried to prove the hypothesis whether diabetes mellites is an afresh possible sequala of covid infection by systematically evaluating the consistently changing glucose level of the post covid patients. The databases PubMed and Google Scholar were searched for this purpose. This review study was done by systematically searching the peer-reviewed literatures on new-onset DM as a post covid condition by analysing articles between January 2020 and January 2022. The articles for review include studies on the patients with lingering clinical signs noted and biochemical alterations showing DM as a sequala of post covid infection a least a month after recovery. Thus, this study confirms that selected number of patients are diagnosed with diabetes as a new-onset disease after recovery from the covid infection. The changes noted in the blood glucose level after covid infection confirms the important of considering DM as post covid diagnostic criteria to give proof based clinical care.

Keywords: New-onset diabetes mellitus, Post-COVID syndrome, Long-COVID, SARS-CoV-2, Hyperglycemia, COVID-19 sequelae

[This article belongs to Research and Reviews : A Journal of Immunology ]

How to cite this article:
Michael Sanjeev Kumar, Viji Michael Sanjeev Kumar. Post Covid-Sequela: Novel-Inception of DM: A Review. Research and Reviews : A Journal of Immunology. 2026; 16(02):-.
How to cite this URL:
Michael Sanjeev Kumar, Viji Michael Sanjeev Kumar. Post Covid-Sequela: Novel-Inception of DM: A Review. Research and Reviews : A Journal of Immunology. 2026; 16(02):-. Available from: https://journals.stmjournals.com/rrjoi/article=2026/view=244201


References

  1. Metwally AA, Mehta P, Johnson BS, Nagarjuna A, Snyder MP. COVID-19-induced new-onset diabetes: trends and technologies. Diabetes. 2021;70(12):2733-2744. doi:10.2337/dbi21-0029.
  2. Centers for Disease Control and Prevention (CDC). Post-COVID conditions [Internet]. Atlanta (GA): CDC; 2022 [cited 2026 May 14]. Available from: Post-COVID Conditions
  3. National Health Service (NHS). Long-term effects of coronavirus (long COVID) [Internet]. London: NHS; 2022 [cited 2026 May 14]. Available from: Long COVID Information
  4. World Health Organization (WHO). Coronavirus disease (COVID-19): post COVID-19 condition [Internet]. Geneva: WHO; 2022 [cited 2026 May 14]. Available from: Post COVID-19 Condition
  5. Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098. doi:10.1136/bmj.n1098.
  6. Shrestha DB, Budhathoki P, Raut S, Adhikari S, Ghimire P, Thapaliya S, et al. New-onset diabetes in COVID-19 and clinical outcomes: a systematic review and meta-analysis. World J Virol. 2021;10(5):275-287. doi:10.5501/wjv.v10.i5.275.
  7. Muhamad SA, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A. COVID-19 and hypertension: the what, the why and the how. Front Physiol. 2021;12:665064. doi:10.3389/fphys.2021.665064.
  8. Montefusco L, Ben Nasr M, D’Addio F, Loretelli C, Rossi A, Pastore I, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3(6):774-785. doi:10.1038/s42255-021-00407-6.
  9. American Diabetes Association (ADA). Diagnosis [Internet]. Arlington (VA): ADA; 2022 [cited 2026 May 14]. Available from: Diabetes Diagnosis Information
  10. Centers for Disease Control and Prevention (CDC). Long COVID or post-COVID conditions [Internet]. Atlanta (GA): CDC; 2022 [cited 2026 May 14]. Available from: Long COVID or Post-COVID Conditions
  11. Chen M, Zhu B, Chen D, Hu X, Xu X, Shen WJ, et al. COVID-19 may increase the risk of insulin resistance in adult patients without diabetes: a 6-month prospective study. Endocr Pract. 2021;27(8):834-841. doi:10.1016/j.eprac.2021.04.017.
  12. Nesan G, Keerthana D, Yamini R, Jain T, Kumar D, Eashwer A, et al. 3-month symptom-based ambidirectional follow-up study among recovered COVID-19 patients from a tertiary care hospital using telehealth in Chennai, India. Inquiry. 2021;58:469580211060165. doi:10.1177/00469580211060165.
  13. Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ. 2021;372:n693. doi:10.1136/bmj.n693.
  14. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232. doi:10.1016/S0140-6736(20)32656-8.
  15. Banerjee M, Pal R, Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes. 2022;16(5):591-593. doi:10.1016/j.pcd.2022.06.002.
  16. Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020;18(9):2128-2130.e2. doi:10.1016/j.cgh.2020.04.040.
  17. Wu J, Mackie SL, Pujades-Rodriguez M. Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. BMJ Open Diabetes Res Care. 2020;8(1):e001220. doi:10.1136/bmjdrc-2020-001220.
  18. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618-625. doi:10.1111/j.1365-2362.2009.02153.x.
  19. Shaharuddin SH, Wang V, Santos RS, Gross A, Wang Y, Jawanda H, et al. Deleterious effects of SARS-CoV-2 infection on human pancreatic cells. Front Cell Infect Microbiol. 2021;11:678482. doi:10.3389/fcimb.2021.678482.
  20. Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, et al. Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proc Natl Acad Sci U S A. 2021;118(8):e2101071118. doi:10.1073/pnas.2101071118.
  21. Cappon G, Vettoretti M. SARS-CoV-2-induced post-translational protein modifications: a trigger for developing autoimmune diabetes? Diabetes Metab Res Rev. 2022;38(4):e3508. doi:10.1002/dmrr.3508.
  22. Steenblock C, Richter S, Berger I, Barovic M, Schmid J, Schubert U, et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun. 2021;12(1):3534. doi:10.1038/s41467-021-23886-3.
  23. Wagner C, Griesel M, Mikolajewska A, Mueller A, Nothacker M, Kley K, et al. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2021;8(8):CD014963. doi:10.1002/14651858.CD014963.
  24. Steenblock C, Schwarz PEH, Ludwig B, Linkermann A, Zimmet P, Kulebyakin K, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9(11):786-798. doi:10.1016/S2213-8587(21)00244-8.
  25. Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7:9110. doi:10.1038/s41598-017-09536-z.
  26. Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, et al. Pre-fusion structure of a human coronavirus spike protein. Nature. 2016;531(7592):118-121. doi:10.1038/nature17200.
  27. Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328(7):676-678. doi:10.1001/jama.2022.11691.
  28. Alharthi MH, Alghamdi FA, Alghamdi MA, Alshahrani M, Alzahrani M, Alshahrani H, et al. The association between SARS-CoV-2 infection and diabetic ketoacidosis in patients with new-onset diabetes: a retrospective study from a diabetic center in Saudi Arabia. Pediatr Rep. 2022;14(4):519-527. doi:10.3390/pediatric14040060.
Regular Issue Subscription Review Article
Volume 16
Issue 02
Received 30/01/2026
Accepted 27/03/2026
Published 18/05/2026
Publication Time 108 Days
6

Login


My IP

PlumX Metrics